First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

1. Soria, J.-C.
2. Tan, D.S.W.
3. Chiari, R.
4. Wu, Y.-L.
5. Paz-Ares, L.
6. Wolf, J.
7. Geater, S.L.
8. Orlov, S.
9. Cortinovis, D.
10. Yu, C.-J.
11. Hochmair, M.
12. Cortot, A.B.
13. Tsai, C.-M.
14. Moro-Sibilot, D.
15. Campelo, R.G.
16. McCulloch, T.
17. Sen, P.
18. Dugan, M.
19. Pantano, S.
20. Branle, F.
21. Massacesi, C.
22. de Castro, G.